# Nicola Longo, M.D., Ph.D. – FDA Inspection, Mar 10, 2023

Source: https://www.keypedia.com/records/fda_inspections/nicola-longo-md-phd/1c332952-9ec7-49c4-86c4-b8e0065b562b
Source feed: FDA_Inspections

> FDA inspection 1199605 of Nicola Longo, M.D., Ph.D., March 10, 2023. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199605
- Company Name: Nicola Longo, M.D., Ph.D.
- Inspection Date: 2023-03-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 864458 - 2014-01-13](https://www.keypedia.com/records/fda_inspections/nicola-longo-md-phd/6968926d-ebeb-45b5-acd6-584bfa80f6dd)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/theressa-b-smith/80f0c339-7eac-4c73-b9f6-ecb368738fe6)

Company: https://www.keypedia.com/companies/nicola-longo-md-phd/6804c8d4-45f2-4d4f-aff5-53f75efcd948

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
